Back to companies

Odonate Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Odonate Inc is a biopharmaceutical company focused on developing the oral taxane chemotherapy agent tesetaxel for cancer treatment. The company is headquartered in New York City, New York, the US.

 Gain a 360-degree view of Odonate Inc and make more informed decisions for your business Gain a 360-degree view of Odonate Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 10th Floor, 3 East 28th Street, New York City, 10016
Website www.odonate.com
Telephone 1 332 2060935
No of Employees 137
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange ODTC (OTC)
EPS XYZ
Net Income (0 vs) XYZ -13% (0 vs -1)
Market Cap* $52.7M
   
   
* As of and is in US$
View Odonate Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Odonate Inc premium industry data and analytics

6

Clinical Trials

Determine Odonate Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

3

Catalyst Calendar

Proactively evaluate Odonate Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

Pipeline Drugs

Identify which of Odonate Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

Image for loader
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Odonate Inc key executives to enhance your sales strategy Gain insight into Odonate Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?